The most recent listing of current clinical trials for liver, pancreas and biliary tract cancers appears below. Should you be interested in learning more about any of these clinical trials, please use our Contact Us form.
Site: Liver, Pancreas and Biliary
(Includes Liver, Pancreas
and Biliary Tract)
| Protocol ID |
|
Title |
|
| GV-001.004 |
|
A Randomized, Phase II/ III Study of TNFerade Biologic with 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer
Keywords: Unresectable Locally Advanced Pancreatic Cancer |
|
| GI-4000 |
|
A Phase II Double-Blind, Placebo Controlled, Multi-center Adjuvant Trial of the Efficacy, Immunogenicity, and Safety of GI-4000; an Inactivated Recombinant Saccharomyces Cerevisiae Expressing Mutant Ras Protein Combine with a Gemcitabine Regimen v. a Gemcitabne Regimen with Placebo, in Patients with Post-Resection R0/R1 Pancreatic Cancer with Tumor Sequence Confirmation of Ras Mutations
Keywords: Patients with Post-Resection R0/R1 Pancreatic Cancer with Tumor Sequence Confirmation of Ras Mutations |
|
| Industry-pancreas |
|
A Randomized Phase III Study of Weekly ABI-007 plus Gemcitabine v. Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
Keywords: Metastatic Adenocarcinoma of the Pancreas |
|
| Industry-pancreas |
|
A Global, Multi-Center, Open Label, Phase II Study of AGS-1C4D4 Given in Combination with Gemcitabine in Subjects with Metastatic Pancreatic Cancer
Keywords: Metastatic Pancreatic Cancer |
|
| S0809 |
|
A Phase II Trial of Adjuvant Capecitabine/ Gemcitabine Chemotherapy Followed by Concurrent Capecitabine and Radiotherapy in Extrahepatic Cholangiocarcinoma (EHCC)
Keywords: Extrahepatic Cholangiocarcinoma |
|
| ACOSOG |
|
A Phase II Study of Preoperative Gemcitabine and Erlotinib Plus Pancreatectomy and Postoperative Gemcitabine and Erlotinib for Patients with Operable Pancreatic Adenocarcinoma
Keywords: Operable Pancreatic Adenocarcinoma |